Replies to post #7347 on Halozyme Therapeutics Inc (HALO)

[easycomeandgo]

I doubt very much that we are looking at a choice Halozyme made. The conversion was done to suit the lender. The chorus of recommendations also. The lender liquidating the stock around these prices is a double +/-. Not bad. I would take it, in light of world economic outlook. As to Halozyme buying this stock back at these prices, it makes zero sense.

I agree with those no longer dazzled by the financial engineering.